Reply: Pirtobrutinib: A New and Distinctive Treatment Option for B-Cell Malignancies

MeSH terms

• Adenine / administration & dosage
• Adenine / analogs & derivatives
• Adenine / therapeutic use
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use
• Humans
• Piperidines* / administration & dosage
• Piperidines* / therapeutic use
• Protein Kinase Inhibitors / administration & dosage
• Protein Kinase Inhibitors / therapeutic use
• Pyrazoles / administration & dosage
• Pyrazoles / therapeutic use
• Pyrimidines* / administration & dosage
• Pyrimidines* / therapeutic use